CN Patent

CN113444144A — 一种蛋白酶抑制剂及其药物组合物和用途

Assigned to Individual · Expires 2021-09-28 · 5y expired

What this patent protects

本发明公开了一种蛋白酶抑制剂及其药物组合物和用途，蛋白酶抑制剂含有下式所示的化合物或其立体异构体、药学上可接受的盐、溶剂化物或结晶， 本发明化合物具有抗SARS‑CoV‑2新型冠状病毒作用。

USPTO Abstract

本发明公开了一种蛋白酶抑制剂及其药物组合物和用途，蛋白酶抑制剂含有下式所示的化合物或其立体异构体、药学上可接受的盐、溶剂化物或结晶， 本发明化合物具有抗SARS‑CoV‑2新型冠状病毒作用。

Drugs covered by this patent

Patent Metadata

Patent number
CN113444144A
Jurisdiction
CN
Classification
—
Expires
2021-09-28
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.